Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIO-KRK-0207: Maintenance Strategies in Metastatic Colorectal Cancer
NCT00973609Phase 3Completed
- Sponsor
- AIO-Studien
- Start
- Aug 2009
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by AIO-Studien. Started Aug 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00973609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973609.